Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Bacterial Infections and Mycoses

  Free Subscription

Articles published in Lancet

Retrieve available abstracts of 134 articles:
HTML format
Text format

Single Articles

    September 2019
  1. REUTER A, Hughes J, Furin J
    Challenges and controversies in childhood tuberculosis.
    Lancet. 2019;394:967-978.
    PubMed     Text format     Abstract available

  2. LANGE C, Dheda K, Chesov D, Mandalakas AM, et al
    Management of drug-resistant tuberculosis.
    Lancet. 2019;394:953-966.
    PubMed     Text format     Abstract available

    Tuberculosis needs accelerated and continued attention.
    Lancet. 2019;394:896.
    PubMed     Text format    

  4. KOSKENVUO L, Lehtonen T, Koskensalo S, Rasilainen S, et al
    Mechanical and oral antibiotic bowel preparation versus no bowel preparation for elective colectomy (MOBILE): a multicentre, randomised, parallel, single-blinded trial.
    Lancet. 2019;394:840-848.
    PubMed     Text format     Abstract available

    August 2019
  5. HAGHBAYAN H, Ballios BG, Coomes EA
    Management of rheumatic mitral stenosis.
    Lancet. 2019;394:637.
    PubMed     Text format    

  6. MCCARRON EP, Monaghan M, Sreenivasan S
    Management of rheumatic mitral stenosis.
    Lancet. 2019;394:636-637.
    PubMed     Text format    

  7. REID MJA, Goosby E
    A tuberculosis-free world: is it a delusion? - Authors' reply.
    Lancet. 2019 Aug 12. pii: S0140-6736(19)31411.
    PubMed     Text format    

  8. ATRE S
    A tuberculosis-free world: is it a delusion?
    Lancet. 2019 Aug 12. pii: S0140-6736(19)31623.
    PubMed     Text format    

  9. ALLEGRETTI JR, Mullish BH, Kelly C, Fischer M, et al
    The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications.
    Lancet. 2019;394:420-431.
    PubMed     Text format     Abstract available

  10. OLIVIER-GOUGENHEIM L, Freychet C, Collardeau-Frachon S, Roure-Sobas C, et al
    A quest for Q fever.
    Lancet. 2019;394:419.
    PubMed     Text format    

    Building capacity in Africa's national science academies.
    Lancet. 2019;394:360.
    PubMed     Text format    

    July 2019
  12. BASHAM CA, Elias B, Orr P
    Tuberculosis elimination in Canada.
    Lancet. 2019;394:300-301.
    PubMed     Text format    

  13. MENZIES D, Benedetti A, Migliori GB, Nahid P, et al
    Multidrug-resistant tuberculosis - Authors' reply.
    Lancet. 2019;394:299-300.
    PubMed     Text format    

  14. CHIANG CY, Van Deun A, Trebucq A, Piubello A, et al
    Multidrug-resistant tuberculosis.
    Lancet. 2019;394:299.
    PubMed     Text format    

  15. CAMINERO JA, Garcia-Basteiro AL, Rendon A
    Multidrug-resistant tuberculosis.
    Lancet. 2019;394:298.
    PubMed     Text format    

  16. NYANG'WA BT, Berry C, Fielding K, Nunn AJ, et al
    Multidrug-resistant tuberculosis.
    Lancet. 2019;394:298-299.
    PubMed     Text format    

  17. CARLSON CJ, Mendenhall E
    Preparing for emerging infections means expecting new syndemics.
    Lancet. 2019;394:297.
    PubMed     Text format    

  18. LAVOIE PM, Popescu CR, Molyneux EM, Wynn JL, et al
    Rethinking management of neonates at risk of sepsis.
    Lancet. 2019;394:279-281.
    PubMed     Text format    

  19. MOAZEN B, Assari S, Neuhann F, Stover H, et al
    The guidelines on infection control in prisons need revising.
    Lancet. 2019;394:301-302.
    PubMed     Text format    

  20. WANG HH, Lau E, Horton R, Jiang B, et al
    The Wakley-Wu Lien Teh Prize Essay 2019: telling the stories of Chinese doctors.
    Lancet. 2019;394:11.
    PubMed     Text format    

    June 2019

  21. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study.
    Lancet. 2019 Jun 27. pii: S0140-6736(19)30721.
    PubMed     Text format     Abstract available

  22. KNIGHT M, Chiocchia V, Partlett C, Rivero-Arias O, et al
    Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trial.
    Lancet. 2019;393:2395-2403.
    PubMed     Text format     Abstract available

  23. MORI Y, Katasako A, Matsunaga S, Matono T, et al
    Tetanus: remember to vaccinate.
    Lancet. 2019;393:2331.
    PubMed     Text format    

    May 2019
  24. RYAN JM, Feder HM Jr
    Dog licks baby. Baby gets Pasteurella multocida meningitis.
    Lancet. 2019;393:e41.
    PubMed     Text format    

  25. USHER AD
    Low-cost pneumonia vaccine breaks into global market.
    Lancet. 2019;393:2025-2026.
    PubMed     Text format    

  26. FRIEBEL R, Silverman R, Glassman A, Chalkidou K, et al
    On results reporting and evidentiary standards: spotlight on the Global Fund.
    Lancet. 2019;393:2006-2008.
    PubMed     Text format    

  27. KIRKCALDY RD, Workowski KA
    Gentamicin as an alternative treatment for gonorrhoea.
    Lancet. 2019 May 2. pii: S0140-6736(19)30244.
    PubMed     Text format    

  28. ROSS JDC, Brittain C, Cole M, Dewsnap C, et al
    Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
    Lancet. 2019 May 2. pii: S0140-6736(18)32817.
    PubMed     Text format     Abstract available

    April 2019
  29. ZHONG D, Yi Y, Lin C
    A kidney changes size: first increasing and then decreasing.
    Lancet. 2019;393:1641.
    PubMed     Text format    

  30. YEN LM, Thwaites CL
    Lancet. 2019;393:1657-1668.
    PubMed     Text format     Abstract available

  31. KLUGMAN KP, Rodgers GL
    Population versus individual protection by pneumococcal conjugate vaccination.
    Lancet. 2019 Apr 15. pii: S0140-6736(19)30039.
    PubMed     Text format    

  32. HAMMITT LL, Etyang AO, Morpeth SC, Ojal J, et al
    Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study.
    Lancet. 2019 Apr 15. pii: S0140-6736(18)33005.
    PubMed     Text format     Abstract available

  33. PAN D, Arkell P, Stone NRH, Parkinson B, et al
    Delayed Strongyloides stercoralis hyperinfection syndrome in a renal transplant patient with Pneumocystis jirovecii pneumonia receiving high-dose corticosteroids.
    Lancet. 2019;393:1536.
    PubMed     Text format    

    Disease X and other unknowns.
    Lancet. 2019;393:1496-1497.
    PubMed     Text format    

    March 2019
  35. ABUBAKAR I, Plasencia A, Barnighausen T, Froeschl G, et al
    Horizon Europe: towards a European agenda for global health research and innovation.
    Lancet. 2019;393:1272-1273.
    PubMed     Text format    

  36. MIMOZ O, Guenezan J
    No benefit of chlorhexidine bathing in non-critical care units.
    Lancet. 2019;393:1179-1180.
    PubMed     Text format    

  37. HUANG SS, Septimus E, Kleinman K, Moody J, et al
    Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial.
    Lancet. 2019;393:1205-1215.
    PubMed     Text format     Abstract available

  38. ZUCCALA E, Horton R
    Time to bring tuberculosis out of the shadows.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30486.
    PubMed     Text format    

  39. KI-MOON B
    Building a tuberculosis-free world on a foundation of universal health coverage.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30433.
    PubMed     Text format    

    Nandita Venkatesan: a voice of hope for tuberculosis survivors.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30582.
    PubMed     Text format    

  41. NADDA JP
    India's leadership to end tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30487.
    PubMed     Text format    

  42. KUMAR A
    Picturing health: it's time to act on tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30583.
    PubMed     Text format    

    Inuit research raises concerns about tuberculosis eradication.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30681.
    PubMed     Text format    

  44. REID MJA, Arinaminpathy N, Bloom A, Bloom BR, et al
    Building a tuberculosis-free world: The Lancet Commission on tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30024.
    PubMed     Text format    

  45. FURIN J, Cox H, Pai M
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30308.
    PubMed     Text format     Abstract available

  46. WATTS G
    Christine Sekaggya-Wiltshire: prizewinner in HIV-tuberculosis research.
    Lancet. 2019 Mar 19. pii: S0140-6736(19)30644.
    PubMed     Text format    

  47. FADEL SA, Boschi-Pinto C, Yu S, Reynales-Shigematsu LM, et al
    Trends in cause-specific mortality among children aged 5-14 years from 2005 to 2016 in India, China, Brazil, and Mexico: an analysis of nationally representative mortality studies.
    Lancet. 2019;393:1119-1127.
    PubMed     Text format     Abstract available

  48. AZZOPARDI PS, Hearps SJC, Francis KL, Kennedy EC, et al
    Progress in adolescent health and wellbeing: tracking 12 headline indicators for 195 countries and territories, 1990-2016.
    Lancet. 2019;393:1101-1118.
    PubMed     Text format     Abstract available

  49. PAGE KR, Doocy S, Reyna Ganteaume F, Castro JS, et al
    Venezuela's public health crisis: a regional emergency.
    Lancet. 2019 Mar 11. pii: S0140-6736(19)30344.
    PubMed     Text format     Abstract available

  50. OLMEDO-RENEAUM A, Garcia-Juarez I, Toapanta-Yanchapaxi L, De La Pena-Lopez R, et al
    Rogue "stem cell clinic" leads to Mycobacterium abscessus infection.
    Lancet. 2019;393:918.
    PubMed     Text format    

    February 2019
  51. STORY A, Aldridge RW, Smith CM, Garber E, et al
    Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial.
    Lancet. 2019 Feb 21. pii: S0140-6736(18)32993.
    PubMed     Text format     Abstract available

  52. FRASER H, Keshavjee S
    Video-observed therapy for tuberculosis: strengthening care.
    Lancet. 2019 Feb 21. pii: S0140-6736(19)30293.
    PubMed     Text format    

  53. KUMAR A, Lambert S, Lockwood DNJ
    Picturing health: a new face for leprosy.
    Lancet. 2019;393:629-638.
    PubMed     Text format    

    Abandoning the stigma of leprosy.
    Lancet. 2019;393:378.
    PubMed     Text format    

  55. GOSTIN L, Phelan A, Coutinho AG, Eccleston-Turner M, et al
    Ebola in the Democratic Republic of the Congo: time to sound a global alert?
    Lancet. 2019 Feb 1. pii: S0140-6736(19)30243.
    PubMed     Text format    

    January 2019
  56. CHEKHCHAR M, Hajji I, Madiq B, Darfaoui Z, et al
    Mitral stenosis found after eye problem.
    Lancet. 2019;393:275.
    PubMed     Text format    

    Lancet. 2019;393:218.
    PubMed     Text format    

  58. Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial.
    Lancet. 2019 Jan 8. pii: S0140-6736(18)32221.
    PubMed     Text format     Abstract available

  59. DOYLE LW, Cheong JLY
    Does bovine lactoferrin prevent late-onset neonatal sepsis?
    Lancet. 2019 Jan 8. pii: S0140-6736(18)32390.
    PubMed     Text format    

  60. FERRY G
    Dorothy Stopford Price and the control of tuberculosis in Ireland.
    Lancet. 2019;393:20.
    PubMed     Text format    

    December 2018
  61. SAVIOLI L, Daumerie D
    WHO leadership is essential for the elimination of NTDs.
    Lancet. 2018;390:2765.
    PubMed     Text format    

  62. YAQUB F
    2017: a year in review.
    Lancet. 2018;390:2753-2754.
    PubMed     Text format    

    Our responsibility to protect the Rohingya.
    Lancet. 2018;390:2740.
    PubMed     Text format    

  64. BLUMENTHAL KG, Peter JG, Trubiano JA, Phillips EJ, et al
    Antibiotic allergy.
    Lancet. 2018 Dec 14. pii: S0140-6736(18)32218.
    PubMed     Text format     Abstract available

  65. OLSAVSZKY V, Geraud C
    Liaison leads to solitary syphilitic chancre on the neck.
    Lancet. 2018;392:2397.
    PubMed     Text format    

  66. VAN DER HEIJDE D, Baraliakos X, Gensler LS, Maksymowych WP, et al
    Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial.
    Lancet. 2018;392:2378-2387.
    PubMed     Text format     Abstract available

  67. MEASE P, Coates LC, Helliwell PS, Stanislavchuk M, et al
    Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial.
    Lancet. 2018;392:2367-2377.
    PubMed     Text format     Abstract available

  68. MBONYE AK, Sekamatte M
    Disease outbreaks and reporting in Uganda.
    Lancet. 2018;392:2347-2348.
    PubMed     Text format    

    November 2018

  69. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Lancet. 2018;392:1859-1922.
    PubMed     Text format     Abstract available

  70. MARMORA L, Casas CP, Grubb I, McClure C, et al
    Long-acting technologies for infectious diseases in LMICs.
    Lancet. 2018;392:1610-1611.
    PubMed     Text format    

    Is the global tuberculosis control strategy too big to fail?
    Lancet. 2018 Nov 1. pii: S0140-6736(18)32751.
    PubMed     Text format    

    October 2018
  72. HOCKING JS, Temple-Smith M, Guy R, Donovan B, et al
    Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial.
    Lancet. 2018;392:1413-1422.
    PubMed     Text format     Abstract available

  73. ADAMSON PC, Klausner JD
    No benefit of chlamydia screening in primary care?
    Lancet. 2018;392:1381-1383.
    PubMed     Text format    

  74. MARKS F, Kim JH, Rakotozandrindrainy R
    Madagascar should introduce typhoid conjugate vaccines now.
    Lancet. 2018;392:1309-1310.
    PubMed     Text format    

  75. KLEBANOFF MA, Brotman RM
    Treatment of bacterial vaginosis to prevent preterm birth.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)32115.
    PubMed     Text format    

  76. SUBTIL D, Brabant G, Tilloy E, Devos P, et al
    Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)31617.
    PubMed     Text format     Abstract available

    Congenital syphilis in the USA.
    Lancet. 2018;392:1168.
    PubMed     Text format    

    UN High-Level meeting to end tuberculosis disappointing.
    Lancet. 2018 Oct 3. pii: S0140-6736(18)32458.
    PubMed     Text format    

    September 2018
  79. MAKONI M
    Inside Zimbabwe's efforts to tame cholera.
    Lancet. 2018;392:e8.
    PubMed     Text format    

  80. MARAIS B, Zumla A
    Advancing global tuberculosis control after the UNGA-HLM.
    Lancet. 2018 Sep 24. pii: S0140-6736(18)32361.
    PubMed     Text format    

    Monkeypox contacts: a puzzling problem.
    Lancet. 2018;392:986.
    PubMed     Text format    

  82. TRIPATHI M, Mohindra S
    Rhinocerebral aspergillosis.
    Lancet. 2018;392:e8.
    PubMed     Text format    

  83. AHMAD N, Ahuja SD, Akkerman OW, Alffenaar JC, et al
    Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
    Lancet. 2018;392:821-834.
    PubMed     Text format     Abstract available

    Better and safer treatment for multidrug-resistant tuberculosis.
    Lancet. 2018;392:798-800.
    PubMed     Text format    

  85. REUTER A, Furin J
    Reducing harm in the treatment of multidrug-resistant tuberculosis.
    Lancet. 2018;392:797-798.
    PubMed     Text format    

    August 2018
    Experts fear a resurgence of leprosy in India.
    Lancet. 2018;392:624-625.
    PubMed     Text format    

  87. THWAITES GE, Szubert A, Walker AS
    Rifampicin in treating S aureus bacteraemia - Authors' reply.
    Lancet. 2018;392:555-556.
    PubMed     Text format    

  88. RIEG S, Kern WV, Soriano A
    Rifampicin in treating S aureus bacteraemia.
    Lancet. 2018;392:554-555.
    PubMed     Text format    

    Zika-associated health and development problems in children.
    Lancet. 2018;392:532.
    PubMed     Text format    

  90. MBOI N, Murty Surbakti I, Trihandini I, Elyazar I, et al
    On the road to universal health care in Indonesia, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet. 2018;392:581-591.
    PubMed     Text format     Abstract available

  91. BURZA S, Croft SL, Boelaert M
    Lancet. 2018 Aug 17. pii: S0140-6736(18)31204.
    PubMed     Text format     Abstract available

  92. GARBARINO MC, Cani V, Mazzarello P
    A century ago: Carlo Forlanini and the first successful treatment of tuberculosis.
    Lancet. 2018;392:475.
    PubMed     Text format    

    Introducing EU-wide surveillance of Lyme neuroborreliosis.
    Lancet. 2018;392:452.
    PubMed     Text format    

    July 2018
  94. WALLACE DJ, Furie RA, Tanaka Y, Kalunian KC, et al
    Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Lancet. 2018;392:222-231.
    PubMed     Text format     Abstract available

  95. GUPTA-WRIGHT A, Corbett EL, van Oosterhout JJ, Wilson D, et al
    Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31267.
    PubMed     Text format     Abstract available

    New strategies for inpatients with HIV and tuberculosis.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31442.
    PubMed     Text format    

  97. SEALE AC, Agarwal R
    Improving management of neonatal infections.
    Lancet. 2018;392:100-102.
    PubMed     Text format    

  98. KARTHIKEYAN G, Guilherme L
    Acute rheumatic fever.
    Lancet. 2018;392:161-174.
    PubMed     Text format     Abstract available

  99. SAHA SK, Schrag SJ, El Arifeen S, Mullany LC, et al
    Causes and incidence of community-acquired serious infections among young children in south Asia (ANISA): an observational cohort study.
    Lancet. 2018;392:145-159.
    PubMed     Text format     Abstract available

    June 2018
  100. KRAEF C, Arand J, Veletzky L, Schafer H, et al
    Schistosomiasis detected during appendectomy.
    Lancet. 2018;391:2546.
    PubMed     Text format    

  101. CECCONI M, Evans L, Levy M, Rhodes A, et al
    Sepsis and septic shock.
    Lancet. 2018 Jun 21. pii: S0140-6736(18)30696.
    PubMed     Text format     Abstract available

  102. XIE X, Bai J
    Concentric circles in left atrium.
    Lancet. 2018;391:2448.
    PubMed     Text format    

  103. SALAMA PJ, Embarek PKB, Bagaria J, Fall IS, et al
    Learning from listeria: safer food for all.
    Lancet. 2018;391:2305-2306.
    PubMed     Text format    

    Active case finding for communicable diseases in prisons.
    Lancet. 2018;391:2186.
    PubMed     Text format    

  105. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016.
    Lancet. 2018;391:2236-2271.
    PubMed     Text format     Abstract available

    May 2018
  106. CHATTOPADHYAY A, Sharma A, Gupta K, Jain S, et al
    The Phemister triad.
    Lancet. 2018;391:e20.
    PubMed     Text format    

    Balancing treatment with resistance in UTIs.
    Lancet. 2018;391:1966.
    PubMed     Text format    

  108. QADRI F, Azad AK, Flora MS, Khan AI, et al
    Emergency deployment of oral cholera vaccine for the Rohingya in Bangladesh.
    Lancet. 2018;391:1877-1879.
    PubMed     Text format    

  109. LESSLER J, Moore SM, Luquero FJ, McKay HS, et al
    Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scales.
    Lancet. 2018;391:1908-1915.
    PubMed     Text format     Abstract available

  110. MINTZ E
    Taking aim at cholera.
    Lancet. 2018;391:1868-1870.
    PubMed     Text format    

  111. COUSINS S
    Managing MDR tuberculosis in Nepal.
    Lancet. 2018;391:1760-1761.
    PubMed     Text format    

  112. GUENOT M
    Roger Glass: celebrating the Fogarty at 50.
    Lancet. 2018;391:1765.
    PubMed     Text format    

    April 2018
  113. CHU DK, Kim LH, Young PJ, Zamiri N, et al
    Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis.
    Lancet. 2018;391:1693-1705.
    PubMed     Text format     Abstract available

    The Global Fund links with Lombard Odier bank.
    Lancet. 2018;391:1674-1675.
    PubMed     Text format    

  115. MITJA O, Godornes C, Houinei W, Kapa A, et al
    Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study.
    Lancet. 2018;391:1599-1607.
    PubMed     Text format     Abstract available

  116. BARNETT R
    Lancet. 2018;391:1471.
    PubMed     Text format    

    March 2018
  117. PARK KB, Khan U, Seung K
    Open letter to The Global Fund about its decision to end DPRK grants.
    Lancet. 2018;391:1257.
    PubMed     Text format    

  118. SHARMA D
    Commitments to an end to tuberculosis renewed in India.
    Lancet. 2018;391:1138.
    PubMed     Text format    

  119. GOOSBY E, Jamison D, Swaminathan S, Reid M, et al
    The Lancet Commission on tuberculosis: building a tuberculosis-free world.
    Lancet. 2018;391:1132-1133.
    PubMed     Text format    

  120. WINGFIELD T, Tovar MA, Datta S, Saunders MJ, et al
    Addressing social determinants to end tuberculosis.
    Lancet. 2018;391:1129-1132.
    PubMed     Text format    

  121. DAVIES R
    Leo Martinez: striving to end childhood tuberculosis.
    Lancet. 2018 Mar 21. pii: S0140-6736(18)30680.
    PubMed     Text format    

  122. MCCALL C
    Rheumatic heart disease in the Pacific island nations.
    Lancet. 2018;391:926.
    PubMed     Text format    

    February 2018
  123. BURKI T
    End of a cholera epidemic in South Sudan declared.
    Lancet. 2018;391:647.
    PubMed     Text format    

  124. MUHSEN K, Green MS, Soskolne V, Neumark Y, et al
    Inequalities in non-communicable diseases in Israel - Authors' reply.
    Lancet. 2018;391:537.
    PubMed     Text format    

  125. WATTS N, Amann M, Ayeb-Karlsson S, Belesova K, et al
    The Lancet Countdown on health and climate change: from 25 years of inaction to a global transformation for public health.
    Lancet. 2018;391:581-630.
    PubMed     Text format    

  126. SMAJS D, Pospisilova P
    Macrolide resistance in yaws.
    Lancet. 2018 Feb 7. pii: S0140-6736(18)30205.
    PubMed     Text format    

    Superbugs and us.
    Lancet. 2018;391:420.
    PubMed     Text format    

    January 2018
    Mega-crisis in DR Congo.
    Lancet. 2018;391:297-298.
    PubMed     Text format    

    A new vaccine for typhoid control.
    Lancet. 2018;391:96.
    PubMed     Text format    

    Tuberculosis: criteria for global leadership?
    Lancet. 2018;391:2.
    PubMed     Text format    

    December 2017
  131. HOLLAND TL, Fowler VG Jr
    Rifampicin for Staphylococcus aureus bacteraemia: give it ARREST.
    Lancet. 2017 Dec 14. pii: S0140-6736(17)33294.
    PubMed     Text format    

  132. THWAITES GE, Scarborough M, Szubert A, Nsutebu E, et al
    Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.
    Lancet. 2017 Dec 14. pii: S0140-6736(17)32456.
    PubMed     Text format     Abstract available

    September 2017
    Tuberculosis and HIV/AIDS: the alien and the predator.
    Lancet. 2017;390:1618-1619.
    PubMed     Text format    

    July 2017
  134. YACOUB M, Mayosi B, ElGuindy A, Carpentier A, et al
    Eliminating acute rheumatic fever and rheumatic heart disease.
    Lancet. 2017;390:212-213.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.